https://lifesciences.mofo.com/ 2026-09-23T13:51:12.938Z daily 1.0 https://lifesciences.mofo.com/page-2 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-3 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-4 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-5 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-6 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-7 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-8 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-9 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-10 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-11 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-12 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-13 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-14 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-15 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-16 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-17 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-18 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-19 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-20 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-21 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-22 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-23 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-24 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-25 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/page-26 2026-09-23T13:51:12.938Z daily 0.8 https://lifesciences.mofo.com/editors 2026-09-23T13:51:12.938Z monthly 0.6 https://lifesciences.mofo.com/about 2026-09-23T13:51:12.938Z monthly 0.6 https://lifesciences.mofo.com/topics/digitalization-of-german-healthcare-system-to-receive-legislative-boost-in-2024 2026-09-14T21:33:33.633Z weekly 0.7 https://lifesciences.mofo.com/topics/non-lab-diagnostics-fda-regulatory-considerations 2026-09-14T21:27:19.203Z weekly 0.7 https://lifesciences.mofo.com/topics/usdas-pvp-system-embraces-transgenic-and-gene-edited-plants 2026-09-14T19:07:47.448Z weekly 0.7 https://lifesciences.mofo.com/topics/upov-updates-explanatory-note-on-essentially-derived-varieties-edvs- 2026-09-14T14:40:33.049Z weekly 0.7 https://lifesciences.mofo.com/topics/is-your-claim-open-or-closed-claim-construction-takes-on-a-new-meaning-in-eye-therapies-llc-v-slayback-pharma-llc 2026-09-12T01:20:10.882Z weekly 0.7 https://lifesciences.mofo.com/topics/what-new-fda-policy-means-for-covid-tests-and-beyond 2026-09-10T16:43:59.793Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-and-international-counterparts-release-best-practices-for-machine-learning-in-medical-device-development 2026-09-10T16:39:28.511Z weekly 0.7 https://lifesciences.mofo.com/topics/rescinding-the-mcitrn-final-rule-cms-seeks-new-approaches-for-innovative-technology-coverage 2026-09-10T16:29:18.812Z weekly 0.7 https://lifesciences.mofo.com/topics/doj-releases-false-claims-act-statistics-for-fiscal-year-2021 2026-09-01T19:17:58.197Z weekly 0.7 https://lifesciences.mofo.com/topics/cms-proposes-to-repeal-mcit-final-rule 2026-09-01T19:11:32.658Z weekly 0.7 https://lifesciences.mofo.com/topics/is_the_future_of_telehealth_in_oigs_hands 2026-09-01T19:07:54.825Z weekly 0.7 https://lifesciences.mofo.com/topics/morrison-and-foerster-partners-speak-at-fdlis-digital-health-technology-and-regulation-conference 2026-09-01T19:04:43.142Z weekly 0.7 https://lifesciences.mofo.com/topics/three-key-takeaways-from-fdlis-panel-discussion-on-fdas-digital-health-center-of-excellence-and-working-with-the-fda-in-the-digital-health-space 2026-09-01T19:01:21.796Z weekly 0.7 https://lifesciences.mofo.com/topics/ai-trends-for-2023-fda-regulatory-blog 2026-09-01T18:58:56.036Z weekly 0.7 https://lifesciences.mofo.com/topics/recent-biden-administration-efforts-on-drug-pricing-uspto-notice-focuses-on-eliminating-inconsistencies-in-uspto-fda-statements 2026-09-01T18:55:44.956Z weekly 0.7 https://lifesciences.mofo.com/topics/ai-trends-for-2022---fda-regulatory 2026-09-01T18:54:00.612Z weekly 0.7 https://lifesciences.mofo.com/topics/the-big-bang-for-sequence-listingsthe-big-bang-for-sequence-listings-new-requirements-in-place-july-1-2022-new-requirements-in-place-july-1-2022 2026-09-01T18:24:29.994Z weekly 0.7 https://lifesciences.mofo.com/topics/the-eu-s-new-proposal-for-plants-developed-using-new-genomic-techniques-how-does-it-compare-to-u-s-regulation- 2026-09-01T18:19:46.159Z weekly 0.7 https://lifesciences.mofo.com/topics/practical-strategies-for-protecting-innovations-under-the-doctrine-of-equivalents 2026-09-01T18:14:16.774Z weekly 0.7 https://lifesciences.mofo.com/topics/usda-pvp-office-waives-deposit-requirement-for-asexually-reproduced-plants 2026-09-01T18:10:18.189Z weekly 0.7 https://lifesciences.mofo.com/topics/top-three-ip-issues-for-agtech-startups 2026-09-01T18:05:05.479Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-in-vitro-diagnostic-regulation-entered-into-force--part-1-of-3 2026-09-01T17:55:51.921Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-in-vitro-diagnostic-regulation-entered-into-force--part-2-of-3 2026-09-01T17:46:01.702Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-in-vitro-diagnostic-regulation-entered-into-force-part-3-of-3 2026-09-01T17:37:17.521Z weekly 0.7 https://lifesciences.mofo.com/topics/hhs-reverses-policy-prohibiting-fda-review-of-lab-developed-tests 2026-09-01T17:18:05.842Z weekly 0.7 https://lifesciences.mofo.com/topics/five-key-takeaways-from-fdas-transparency-of-aiml-enabled-medical-devices-virtual-workshop 2026-09-01T17:00:53.607Z weekly 0.7 https://lifesciences.mofo.com/topics/three-things-to-know-about-fda-s-plausible-mechanism-guidance 2026-09-01T16:55:18.409Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-issues-new-draft-guidance-on-demonstrating-substantial-evidence-of-effectiveness-with-one-clinical-investigation-and-confirmatory-evidence 2026-08-29T04:16:28.355Z weekly 0.7 https://lifesciences.mofo.com/topics/-golden-state-crackdown-unpacking-california-s-landmark-food-safety-act 2026-08-29T04:16:05.495Z weekly 0.7 https://lifesciences.mofo.com/topics/comment-on-morphing-u-s-biotechnology-regulations 2026-08-29T04:14:13.147Z weekly 0.7 https://lifesciences.mofo.com/topics/ftc-alleges-improper-orange-book-listing-of-drug-delivery-device-patents 2026-08-29T04:13:55.284Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-s-lab-developed-test-rule-may-bring-historic-challenges 2026-08-29T04:13:40.397Z weekly 0.7 https://lifesciences.mofo.com/topics/new-plants-old-frameworks-fda-1992-policy-applies-to-foods-derived-from-genome-edited-plants 2026-08-29T04:13:25.316Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-court-invalidates-dosing-patent-based-on-clinical-trials-disclosure 2026-08-29T04:13:09.772Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-term-extension-for-medical-devices 2026-08-29T04:12:43.080Z weekly 0.7 https://lifesciences.mofo.com/topics/hhs-secretary-to-fda-consider-elimination-of-gras-self-affirmation-pathway 2026-08-29T04:12:03.886Z weekly 0.7 https://lifesciences.mofo.com/topics/the-future-of-food-exploring-the-world-of-cell-cultivated-cuisine- 2026-08-29T04:11:41.592Z weekly 0.7 https://lifesciences.mofo.com/topics/another-step-change-for-usda-s-ge-regs-aphis-ceases-nepa-review-of-petitions-for-nonregulated-status 2026-08-29T04:11:23.076Z weekly 0.7 https://lifesciences.mofo.com/topics/three-things-to-know-about-fda-s-newest-draft-guidance-on-cell-gene-therapies 2026-08-29T04:11:06.216Z weekly 0.7 https://lifesciences.mofo.com/topics/texas-sb-25-litigation-trade-associations-challenge-tx-warning-label-requirement 2026-08-29T04:10:48.485Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-s-revised-biosimilar-q-as-three-things-sponsors-should-know 2026-08-29T04:10:32.110Z weekly 0.7 https://lifesciences.mofo.com/topics/new-coverage-pathway-for-medical-devices 2026-08-29T04:09:49.248Z weekly 0.7 https://lifesciences.mofo.com/topics/key-takeaways-from-fdlis-enforcement-litigation-and-compliance-conference-keynote-address 2026-08-29T04:05:06.305Z weekly 0.7 https://lifesciences.mofo.com/topics/3-key-takeaways-from-fdlis-fda-center-compliance-directors-presentations-and-qa-session 2026-08-29T04:04:48.861Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-oks-mail-order-mifepristone-state-laws-may-inhibit-its-use 2026-08-29T04:04:16.432Z weekly 0.7 https://lifesciences.mofo.com/topics/possession-of-an-effective-dose 2026-08-29T04:03:37.707Z weekly 0.7 https://lifesciences.mofo.com/topics/a-day-late-and-a-dollar-short-aag-polite-warns-that-corporate-leaders-who-fail-to-invest-in-compliance-early-and-often-do-so-at-their-own-risk 2026-08-29T04:02:37.856Z weekly 0.7 https://lifesciences.mofo.com/topics/dont-cry-over-spilled-milk-federal-circuit-finds-milk-vitamin-patent-invalid 2026-08-29T04:00:23.376Z weekly 0.7 https://lifesciences.mofo.com/topics/230324-cms-announces-part-b-prescription 2026-08-29T03:59:28.478Z weekly 0.7 https://lifesciences.mofo.com/topics/supreme-court-us-government-has-broad-discretion-to-dismiss-false-claims-act-suits 2026-08-29T03:59:09.825Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-seeks-input-on-experimental-use-exception-to-patent-infringement-and-possible-legislative-action 2026-08-29T03:57:50.032Z weekly 0.7 https://lifesciences.mofo.com/topics/the-ptab-axes-skin-treatment-patent-under-amgen 2026-08-29T03:57:26.561Z weekly 0.7 https://lifesciences.mofo.com/topics/senate-unanimously-passes-bill-to-limit-patent-infringement-challenges-by-drug-manufacturers 2026-08-29T03:55:46.587Z weekly 0.7 https://lifesciences.mofo.com/topics/new-fda-guidance-on-covid-19-vaccines 2026-08-29T03:55:23.811Z weekly 0.7 https://lifesciences.mofo.com/topics/what-is-healthy-are-fats-in- 2026-08-29T03:55:05.124Z weekly 0.7 https://lifesciences.mofo.com/topics/medicare-drug-price-negotiation-program-final-guidance 2026-08-29T03:54:46.918Z weekly 0.7 https://lifesciences.mofo.com/topics/ai-agent-as-a-service-in-medtech-key-considerations-for-commercial-contracts 2026-08-29T03:54:24.972Z weekly 0.7 https://lifesciences.mofo.com/topics/front-of-pack-front-of-mind 2026-08-29T03:54:06.535Z weekly 0.7 https://lifesciences.mofo.com/topics/life-sciences-patent-trends-in-2022--doctrine-of-equivalents 2026-08-29T03:53:43.712Z weekly 0.7 https://lifesciences.mofo.com/topics/cjeu-clarifies-when-a-healthcare-product-is-a-medical-device-under-the-mdr-beyond-the-brochure 2026-08-29T03:53:19.498Z weekly 0.7 https://lifesciences.mofo.com/topics/cms-announces-pause-on-home-health-and-hospice-enrollments-amid-expanding-fraud-crackdown 2026-08-29T03:45:43.336Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-term-extension-for-biologics 2026-08-29T03:45:24.551Z weekly 0.7 https://lifesciences.mofo.com/topics/legal-battles-continue-over-inflation-reduction-act-s-drug-price-negotiation-measures 2026-08-29T03:45:04.276Z weekly 0.7 https://lifesciences.mofo.com/topics/ai-transparency-in-healthcare-navigating-a-changing-regulatory-landscape 2026-08-29T03:44:46.299Z weekly 0.7 https://lifesciences.mofo.com/topics/skinny-labels-back-in-focus-after-hhs-report-on-addressing-drug-prices 2026-08-29T03:44:25.319Z weekly 0.7 https://lifesciences.mofo.com/topics/ending-the-covid-19-public-health-emergency-what-happens-next 2026-08-29T03:44:04.156Z weekly 0.7 https://lifesciences.mofo.com/topics/de-novo-classification-final-rule-to-take-effect-next-year 2026-08-29T03:43:43.664Z weekly 0.7 https://lifesciences.mofo.com/topics/telehealth-fraud-enforcement-trends-predictions-and-best-practices 2026-08-29T03:40:14.751Z weekly 0.7 https://lifesciences.mofo.com/topics/us-government-launches-biomedical-agency 2026-08-29T03:39:51.634Z weekly 0.7 https://lifesciences.mofo.com/topics/prevent-a-clinical-trial-from-turning-into-a-criminal-trial 2026-08-29T03:39:21.170Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-clarifies-anda-active-ingredient-sameness-evaluation-in-draft-guidance 2026-08-29T03:39:01.610Z weekly 0.7 https://lifesciences.mofo.com/topics/cms-publishes-final-2023-medicare-physician-fee-schedule-key-takeaways-for-telehealth-companies 2026-08-29T03:38:31.506Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-publishes-digital-health-technology-framework 2026-08-29T03:38:08.955Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-issues-final-transition-guidances-for-covid-19-devices 2026-08-29T03:36:38.251Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-releases-draft-guidance-on-digital-health-technologies-for-remote-data-acquisition-in-clinical-investigations 2026-08-29T03:36:14.761Z weekly 0.7 https://lifesciences.mofo.com/topics/2022-life-sciences-moforum-starts-this-week 2026-08-29T03:35:52.495Z weekly 0.7 https://lifesciences.mofo.com/topics/united-states-supreme-court-look-to-defendants-subjective-beliefs-to-decide-whether-it-knowingly-submitted-false-claim 2026-08-29T03:35:30.621Z weekly 0.7 https://lifesciences.mofo.com/topics/recordings-now-available-2022-life-sciences-moforum--growth-innovation-and-strategy 2026-08-29T03:34:09.421Z weekly 0.7 https://lifesciences.mofo.com/topics/moforum-recap-transformation-across-the-industry 2026-08-29T03:33:29.687Z weekly 0.7 https://lifesciences.mofo.com/topics/health-app-and-device-providers-take-note-health-breach-notification-rule-enforcement-is-coming 2026-08-29T03:28:53.195Z weekly 0.7 https://lifesciences.mofo.com/topics/latest-genetic-data-privacy-law-goes-into-effect 2026-08-29T03:28:32.600Z weekly 0.7 https://lifesciences.mofo.com/topics/ftc-brings-first-enforcement-action-of-the-health-breach-notification-rule 2026-08-29T03:28:09.146Z weekly 0.7 https://lifesciences.mofo.com/topics/life-sciences-moforum-2024-san-diego-the-state-of-the-life-sciences-industry 2026-08-29T03:27:32.639Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-launches-program-to-defer-subject-matter-eligibility-responses 2026-08-29T03:25:18.261Z weekly 0.7 https://lifesciences.mofo.com/topics/230403-applying-bipa-health-care-exemption 2026-08-29T03:24:53.101Z weekly 0.7 https://lifesciences.mofo.com/topics/privacy-litigation-2022-year-in-review-biometric-information-privacy-act-bipa- 2026-08-29T03:24:24.034Z weekly 0.7 https://lifesciences.mofo.com/topics/bioinformatics-patents--subject-matter-eligibility-in-2022 2026-08-29T03:23:59.986Z weekly 0.7 https://lifesciences.mofo.com/topics/220223-quick-guide-to-jvs-alternative-protein-industry 2026-08-29T03:20:01.041Z weekly 0.7 https://lifesciences.mofo.com/topics/221021-financing-options-early-stage-company-alternative-protein 2026-08-29T03:19:25.520Z weekly 0.7 https://lifesciences.mofo.com/topics/financing-options-in-the-alternative-protein-industry 2026-08-29T03:19:03.105Z weekly 0.7 https://lifesciences.mofo.com/topics/water-is-in-white-bread-is-out-healthy-gets-a-new-look-in-2023 2026-08-29T03:17:48.463Z weekly 0.7 https://lifesciences.mofo.com/topics/when-your-life-sciences-are-on-the-line-protecting-your-company-s-most-valuable-asset-trade-secrets 2026-08-29T03:17:21.428Z weekly 0.7 https://lifesciences.mofo.com/topics/a-long-courtship-for-unity--as-europes-unitary-patent-system-is-going-live-soon-consultations-about-a-unitary-supplementary-protection-certificate-gain-momentum 2026-08-29T03:17:00.543Z weekly 0.7 https://lifesciences.mofo.com/topics/2024-regulatory-compliance-and-enforcement-predictions-for-life-sciences-companies 2026-08-29T03:16:43.129Z weekly 0.7 https://lifesciences.mofo.com/topics/doj-signals-intent-to-increase-antitrust-scrutiny-of-information-sharing 2026-08-29T03:16:23.666Z weekly 0.7 https://lifesciences.mofo.com/topics/chinas-new-seed-law-molecular-varieties-and-macro-developments 2026-08-29T03:07:54.602Z weekly 0.7 https://lifesciences.mofo.com/topics/china-eyes-new-export-controls-for-life-sciences-technologies 2026-08-29T03:07:08.285Z weekly 0.7 https://lifesciences.mofo.com/topics/251024-biosecure-act-passes-senate 2026-08-29T03:06:47.283Z weekly 0.7 https://lifesciences.mofo.com/topics/relabeling-vs-repackaging-cjeu-backs-drug-manufacturers-position-against-parallel-importers 2026-08-29T03:04:57.644Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-mdr-and-ivdr-implementation-new-transitional-regime-enters-into-force 2026-08-29T03:04:37.295Z weekly 0.7 https://lifesciences.mofo.com/topics/update-february-2024-on-commission-plans-liberalization-of-new-genomic-techniques-ngts-in-the-eu 2026-08-29T03:03:51.588Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-mdr-and-ivdr-implementation-signs-of-relaxing-transitioning-regime-and-bridging-measures 2026-08-29T03:03:30.219Z weekly 0.7 https://lifesciences.mofo.com/topics/eu-mdr-and-ivdr-implementation-european-commission-publishes-full-proposal-for-amending-transitional-regime 2026-08-29T03:03:07.755Z weekly 0.7 https://lifesciences.mofo.com/topics/moforum-bayer-co-lab-edition-edition-charting-the-biotech-startup-journey 2026-08-29T03:02:48.626Z weekly 0.7 https://lifesciences.mofo.com/topics/europe-s-new-genomic-techniques-patent-ban-off-the-table 2026-08-29T03:02:16.721Z weekly 0.7 https://lifesciences.mofo.com/topics/commission-plans-liberalization-of-new-genomic-techniques-ngts-in-the-eu 2026-08-29T03:01:52.580Z weekly 0.7 https://lifesciences.mofo.com/topics/key-considerations-for-sponsors-of-clinical-trials-under-the-eu-clinical-trial-regulation 2026-08-29T03:01:33.364Z weekly 0.7 https://lifesciences.mofo.com/topics/standards-for-inventiveness-and-disclosure-for-antibody-claims-across-jurisdictions 2026-08-29T03:01:02.351Z weekly 0.7 https://lifesciences.mofo.com/topics/220913-key-considerations-early-stage-companies-alternative-protein 2026-08-29T02:56:07.647Z weekly 0.7 https://lifesciences.mofo.com/topics/april-2025-update-on-regulation-of-new-genomic-techniques-in-the-eu 2026-08-29T02:55:51.054Z weekly 0.7 https://lifesciences.mofo.com/topics/european-union-adopts-regulation-to-extend-term-of-community-plant-variety-rights-in-europe-for-varieties-of-certain-plant-species 2026-08-29T02:53:19.716Z weekly 0.7 https://lifesciences.mofo.com/topics/fdas-loud-and-clear-message-engage-with-fda-early-and-formally 2026-08-29T02:53:02.931Z weekly 0.7 https://lifesciences.mofo.com/topics/at-any-rate-it-wont-fail-because-of-money 2026-08-29T02:47:30.258Z weekly 0.7 https://lifesciences.mofo.com/topics/in-vineis-veritas-no-sour-grapes-as-egyptian-court-orders-removal-of-illegal-vines 2026-08-29T02:45:25.363Z weekly 0.7 https://lifesciences.mofo.com/topics/fdora-passage-brings-significant-changes-to-fda-s-drug-device-and-cosmetic-authorities 2026-08-29T02:44:59.362Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-finalizes-guidance-on-interpretation-of-orphan-drug-sameness-for-gene-therapy-products 2026-08-29T02:36:49.449Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-reconsiders-obviousness-type-double-patenting-and-proposes-a-new-examination-framework 2026-08-10T23:40:52.338Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-enables-pharmacies-to-dispense-abortion-inducing-mifepristone 2026-07-27T15:43:39.597Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-on-use-of-ai-ml-in-drug-development-five-key-takeaways 2026-07-27T15:36:39.379Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-clarifies-the-human-factors-or-usability-information-to-include-in-a-device-marketing-submission 2026-07-21T00:12:18.791Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-final-food-traceability-rule-overview-and-key-takeaways-from-fda-s-food-safety-modernization-act-webinar 2026-07-21T00:11:06.832Z weekly 0.7 https://lifesciences.mofo.com/topics/the-uspto-and-the-fda-join-hands-to-promote-competition 2026-07-20T22:29:38.364Z weekly 0.7 https://lifesciences.mofo.com/topics/senators-call-for-report-on-state-of-psychedelic-research 2026-07-20T22:27:52.293Z weekly 0.7 https://lifesciences.mofo.com/topics/partnering-with-the-alternative-protein-sector 2026-07-20T22:24:47.013Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-publishes-draft-guidance-for-predetermined-change-control-plan-for-ai-ml-enabled-device-software-functions 2026-07-20T22:17:30.882Z weekly 0.7 https://lifesciences.mofo.com/topics/states-extend-scope-of-regulatory-oversight-of-health-care-entities 2026-07-20T22:09:20.475Z weekly 0.7 https://lifesciences.mofo.com/topics/biden-executive-order-has-potential-to-discourage-u-s-company-participation-in-federal-research 2026-07-20T22:07:36.703Z weekly 0.7 https://lifesciences.mofo.com/topics/microbes-biotech-investigations-and-impacts-midsummer-regulatory-updates-from-usda-aphis 2026-07-20T22:02:52.801Z weekly 0.7 https://lifesciences.mofo.com/topics/usda-and-uspto-promoting-fair-competition-and-innovation-in-the-seed-marketplace 2026-07-20T20:15:14.750Z weekly 0.7 https://lifesciences.mofo.com/topics/data-privacy-at-the-crossroads-of-ai-and-life-sciences-u-s-and-eu-perspectives 2026-07-20T17:45:36.586Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-circuit-addresses-subject-matter-eligibility-for-compositions-of-matter-in-us-synthetic-v-itc 2026-07-20T17:42:06.569Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-vs-trade-secret-considerations-for-cell-and-gene-therapies 2026-07-20T17:34:14.685Z weekly 0.7 https://lifesciences.mofo.com/topics/recent-updates-on-use-of-post-filing-data-as-evidence-to-support-patentability 2026-07-20T17:33:08.538Z weekly 0.7 https://lifesciences.mofo.com/topics/rulings-fda-guidance-may-help-food-cos-in-protein-suits 2026-07-14T18:32:34.738Z weekly 0.7 https://lifesciences.mofo.com/topics/biden-administration-proposes-novel-use-of-price-as-justification-for-agency-exercise-of-march-in-rights-government-funded-inventions 2026-05-14T23:05:30.171Z weekly 0.7 https://lifesciences.mofo.com/topics/usda-aphis-brs-promises-continued-efficiency 2026-03-12T01:14:39.746Z weekly 0.7 https://lifesciences.mofo.com/topics/recombinant-host-cells-are-patent-eligible-federal-circuit-revives-regenxbio-s-gene-delivery-patent 2026-02-24T00:23:41.352Z weekly 0.7 https://lifesciences.mofo.com/topics/blaze-marks-written-description-patent-drafting-lessons-duke-v-sandoz 2026-02-10T17:27:39.716Z weekly 0.7 https://lifesciences.mofo.com/topics/updates-in-uruguay-accession-to-the-pct-and-announcement-of-a-new-gmo-regulatory-framework 2025-12-29T20:01:58.263Z weekly 0.7 https://lifesciences.mofo.com/topics/strategic-filing-of-ai-and-life-sciences-software 2025-12-09T19:22:13.336Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-releases-draft-guidance-for-labeling-of-plant-based-milk-alternatives 2025-09-04T20:31:42.568Z weekly 0.7 https://lifesciences.mofo.com/topics/quality-management-system-regulation-qmsr--harmonizing-the-quality-system-regulation-qsr-with-iso-134852016 2025-09-04T20:29:29.711Z weekly 0.7 https://lifesciences.mofo.com/topics/what-makes-a-good-cell-and-gene-therapy-application- 2025-08-06T16:11:55.838Z weekly 0.7 https://lifesciences.mofo.com/topics/key-developments-in-medtech-m-a-momentum-despite-macroeconomic-uncertainty 2025-07-14T17:26:59.673Z weekly 0.7 https://lifesciences.mofo.com/topics/need-to-fast-track-your-patent-the-uspto-increases-the-annual-limit-to-20-000 2025-07-09T23:38:26.060Z weekly 0.7 https://lifesciences.mofo.com/topics/a-tip-for-improving-your-improved-jepson-claim-include-written-description-support 2025-07-07T19:46:31.540Z weekly 0.7 https://lifesciences.mofo.com/topics/in-patent-prosecution-you-have-the-right-to-remain-silent-anything-you-say-can-and-will-be-used-against-you-in-the-court-of-law 2025-06-17T15:20:03.169Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-eligibility-considerations-prosecution-strategies-for-ai-based-life-sciences-patent-applications 2025-06-17T15:10:57.228Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-discontinues-accelerated-examination-program-in-favor-of-expanding-track-one-program 2025-06-10T16:47:21.549Z weekly 0.7 https://lifesciences.mofo.com/topics/sm-eligibility-of-ai-medical-treatments 2025-06-04T21:47:08.969Z weekly 0.7 https://lifesciences.mofo.com/topics/navigating-u-s-regulatory-requirements-for-genetically-modified-microorganisms-using-interactive-tool 2025-05-14T18:01:51.326Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-circuit-vacates-and-remands-in-long-pending-dispute-over-crispr-ip 2025-05-14T12:21:37.080Z weekly 0.7 https://lifesciences.mofo.com/topics/recentive-raising-the-patent-eligibility-bar-in-ai-related-inventions 2025-04-25T17:47:43.993Z weekly 0.7 https://lifesciences.mofo.com/topics/an-insecure-future-court-ruling-guts-usda-regs-on-genetically-engineered-plants 2025-04-21T19:10:12.463Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-circuit-clarifies-requirements-for-prior-art-under-pre-aia-35-u-s-c-102-e 2025-04-10T15:50:11.401Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-circuit-clarifies-patent-term-extension-calculation-for-reissue-patents 2025-03-24T19:01:29.263Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-draft-guidance-on-artificial-intelligence-enabled-device-software-functions 2025-03-19T18:27:45.881Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-releases-draft-guidance-on-evaluating-the-risk-and-credibility-of-ai-used-in-establishing-drug-and-device-safety-effectiveness-and-quality 2025-03-19T18:26:36.598Z weekly 0.7 https://lifesciences.mofo.com/topics/navigating-obviousness-federal-circuit-addresses-patentability-of-pharmaceutical-dosing-methods 2025-03-10T22:49:23.482Z weekly 0.7 https://lifesciences.mofo.com/topics/250304-navigating-inventorship 2025-03-05T20:21:38.038Z weekly 0.7 https://lifesciences.mofo.com/topics/patents-and-trade-secrets-in-ai-and-life-sciences 2025-02-11T18:27:10.034Z weekly 0.7 https://lifesciences.mofo.com/topics/mofo-life-sciences-blog-post-draft-uspto-fee-changes-for-2025 2025-01-08T01:41:49.973Z weekly 0.7 https://lifesciences.mofo.com/topics/private-sales-may-not-qualify-as-public-disclosure 2025-01-06T23:14:44.789Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-will-once-again-accept-pre-submissions-for-all-in-vitro-diagnostic-tests 2024-12-21T22:05:45.936Z weekly 0.7 https://lifesciences.mofo.com/topics/purple-tomato-is-first-genetically-engineered-plant-to-be-deregulated-through-usda-s-new-regulatory-status-review-process 2024-12-21T21:54:26.370Z weekly 0.7 https://lifesciences.mofo.com/topics/stop-gap-spending-bill-provision-takes-aim-at-biologics-patent-litigation 2024-12-19T23:03:37.832Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-withdraws-consideration-of-controversial-change-to-terminal-disclaimer-practice 2024-12-04T20:48:26.416Z weekly 0.7 https://lifesciences.mofo.com/topics/establishing-unexpected-results-ptab-highlights-pitfalls-for-rule-132-declarations 2024-10-28T21:39:46.237Z weekly 0.7 https://lifesciences.mofo.com/topics/beyond-final-rejection-what-s-next-for-patent-prosecution-after-uspto-terminates-after-final-consideration-program- 2024-10-01T22:10:14.299Z weekly 0.7 https://lifesciences.mofo.com/topics/federal-circuit-clarifies-scope-of-obviousness-type-double-patenting-in-allergan-usa-v-msn-laboratories 2024-09-19T22:05:39.553Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-clears-the-path-to-lab-grown-meat 2024-08-09T17:33:03.504Z weekly 0.7 https://lifesciences.mofo.com/topics/240708-federal-circuit-article-iii-standing-patent-cases 2024-07-08T18:13:40.581Z weekly 0.7 https://lifesciences.mofo.com/topics/last-week-in-the-federal-circuit-august-8-august-12-taking-a-round-trip-on-the-assignor-estoppel-express 2024-05-21T17:21:39.367Z weekly 0.7 https://lifesciences.mofo.com/topics/240512-uspto-considers-changing-terminal-disclaimer-practice 2024-05-12T17:54:04.467Z weekly 0.7 https://lifesciences.mofo.com/topics/cms-releases-guidance-on-the-medicare-prescription-drug-inflation-rebate-program 2024-05-11T00:31:44.951Z weekly 0.7 https://lifesciences.mofo.com/topics/the-legal-and-regulatory-landscape-evolving-with-ai-in-life-sciences 2024-05-11T00:30:12.741Z weekly 0.7 https://lifesciences.mofo.com/topics/new-regulations-rooted-in-evidence-looking-back-on-how-epa-and-usda-updated-engineered-plant-regulations-and-labeling-in-2023 2024-05-11T00:23:44.404Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-clears-crispr-edited-cattle-for-market-through-abbreviated-procedure-a-first-for-food-use-animals 2024-05-10T18:34:47.537Z weekly 0.7 https://lifesciences.mofo.com/topics/new-jersey-court-affirms-prohibition-of-physician-practice-from-opening-and-operating-in-office-pharmacy 2024-05-10T18:19:31.282Z weekly 0.7 https://lifesciences.mofo.com/topics/new-opportunities-for-test-developers-monkeypox-diagnostics 2024-05-10T16:29:54.477Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-issues-reminder-to-examiners-on-proper-means-plus-function-analysis 2024-03-29T19:41:11.931Z weekly 0.7 https://lifesciences.mofo.com/topics/at-home-diagnostics-articles-non-lab-diagnostics-supply-manufacturing-and-distribution-agreements 2024-03-29T13:51:42.006Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-regulatory-considerations 2024-03-20T20:52:45.455Z weekly 0.7 https://lifesciences.mofo.com/topics/how-to-operate-in-the-ai-compliance-vacuum 2024-02-08T00:15:33.875Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-enablement-guidelines-after-amgen-v-sanofi 2024-01-12T17:37:13.596Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-prosecution-strategies-to-avoid-pitfalls-in-post-grant-proceedings 2023-11-14T23:29:11.618Z weekly 0.7 https://lifesciences.mofo.com/topics/mofo-and-bayer-co-lab-kick-off-partnership-to-advance-cell-and-gene-therapy-innovation 2023-11-10T19:53:57.104Z weekly 0.7 https://lifesciences.mofo.com/topics/10-considerations-in-licensing-cleantech-innovations 2023-10-24T02:55:10.395Z weekly 0.7 https://lifesciences.mofo.com/topics/retaining-your-patent-priority-date-in-europe-formal-priority-given-a-rebuttable-presumption-in-favor-of-applicant-patentee 2023-10-20T18:59:37.787Z weekly 0.7 https://lifesciences.mofo.com/topics/patent-term-adjustment-takes-a-hit-in-cellect-decision 2023-09-15T18:42:07.459Z weekly 0.7 https://lifesciences.mofo.com/topics/a-glimmer-of-hope-for-simplified-patenting-of-medical-diagnostics-in-the-united-states 2023-09-06T22:24:11.613Z weekly 0.7 https://lifesciences.mofo.com/topics/5-questions-about-generative-ai-in-healthcare 2023-08-02T19:02:27.287Z weekly 0.7 https://lifesciences.mofo.com/topics/it-takes-two-to-taco-taco-john-s-abandons-taco-tuesday-trademark-registration 2023-08-01T13:32:48.648Z weekly 0.7 https://lifesciences.mofo.com/topics/obviousness-in-drug-combinations-unexpected-results-vs-unexpected-mechanisms-of-action 2023-07-21T22:49:57.223Z weekly 0.7 https://lifesciences.mofo.com/topics/top-10-considerations-for-transactions-involving-alternative-protein-companies 2023-07-18T11:50:25.457Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-releases-draft-guidance-on-use-of-real-world-evidence-for-drug--biological-products 2023-07-10T16:28:07.990Z weekly 0.7 https://lifesciences.mofo.com/topics/mitigating-patent-risk-in-gene-therapy-development 2023-07-10T15:21:04.928Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-issues-draft-guidance-on-human-gene-therapy-products-incorporating-human-genome-editing 2023-07-06T01:27:41.137Z weekly 0.7 https://lifesciences.mofo.com/topics/five-questions-after-amgen-v-sanofi 2023-06-16T21:19:43.377Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-releases-2022-2026-strategic-plan 2023-06-13T15:43:43.212Z weekly 0.7 https://lifesciences.mofo.com/topics/new-york-enacts-material-healthcare-transactions-notice-requirements-four-key-takeaways 2023-05-25T22:09:28.401Z weekly 0.7 https://lifesciences.mofo.com/topics/ip-implications-of-usda-research-collaborations 2023-05-10T16:23:20.287Z weekly 0.7 https://lifesciences.mofo.com/topics/ftc-issues-notice-of-penalty-offenses-on-substantiation-of-product-claims 2023-05-03T16:13:10.215Z weekly 0.7 https://lifesciences.mofo.com/topics/10-considerations-when-licensing-ai-for-drug-discovery 2023-04-28T14:56:57.148Z weekly 0.7 https://lifesciences.mofo.com/topics/is-doe-now-in-vogue 2023-04-21T23:59:08.914Z weekly 0.7 https://lifesciences.mofo.com/topics/uspto-to-launch-new-patent-issue-procedure-on-april-18-what-you-need-to-know 2023-04-13T16:12:15.894Z weekly 0.7 https://lifesciences.mofo.com/topics/u-s-plant-variety-protection-office-invited-comments-on-upov-test-guidelines-and-is-aligning-exhibit-c-forms-with-upov 2023-04-10T20:45:15.922Z weekly 0.7 https://lifesciences.mofo.com/topics/supreme-court-denies-review-of-cost-sharing-assistance-program 2023-02-08T17:26:13.133Z weekly 0.7 https://lifesciences.mofo.com/topics/211101-alternative-protein-insect-protein-as-food-and-feed 2023-02-08T16:36:06.927Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-updates-covid-19-testing-guidances 2023-02-01T18:11:49.367Z weekly 0.7 https://lifesciences.mofo.com/topics/stepping-stones-to-success-supporting-claims-in-the-life-sciences 2023-02-01T16:42:44.978Z weekly 0.7 https://lifesciences.mofo.com/topics/ftc-issues-updated-health-products-claims-guidance 2023-01-31T20:51:35.685Z weekly 0.7 https://lifesciences.mofo.com/topics/cms-reveals-new-details-on-medicare-drug-price-negotiation-program 2023-01-20T22:43:10.961Z weekly 0.7 https://lifesciences.mofo.com/topics/congress-expands-fda-authority-over-cosmetics-regulation 2023-01-13T19:40:23.689Z weekly 0.7 https://lifesciences.mofo.com/topics/cybersecurity-expectations-intensify-for-medical-device-cos 2022-11-02T19:01:47.095Z weekly 0.7 https://lifesciences.mofo.com/topics/germany-ministry-of-health-grants-first-glimpse-on-the-upcoming-cannabis-legalization-and-seeks-green-light-from-the-european-commission 2022-10-28T19:13:02.398Z weekly 0.7 https://lifesciences.mofo.com/topics/sawing-through-patent-term-the-federal-circuit-s-recent-decision-in-sawstop 2022-10-05T21:05:13.846Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-releases-foundational-digital-health-guidance 2022-10-05T17:50:07.602Z weekly 0.7 https://lifesciences.mofo.com/topics/fda-updates-covid-19-test-policy 2022-09-28T20:47:56.537Z weekly 0.7 https://lifesciences.mofo.com/topics/the-importance-of-patents-for-ml-based-medical-device-inventions 2022-09-09T18:59:03.148Z weekly 0.7 https://lifesciences.mofo.com/topics/crispr-s-next-10-years-from-lab-to-plate 2022-08-30T13:23:09.347Z weekly 0.7 https://lifesciences.mofo.com/topics/last-week-in-the-federal-circuit-august-15-august-19-the-court-rebuffs-patent-owner-s-attempt-to-read-anda-application-in-isolation 2022-08-30T13:14:17.041Z weekly 0.7 https://lifesciences.mofo.com/topics/qmsr-welcomed-by-the-industry-but-lacking-in-practicality 2022-07-15T03:34:03.255Z weekly 0.7 https://lifesciences.mofo.com/topics/the-uspto-proposes-to-establish-permanent-electronic-filing-for-patent-term-extension-applications 2022-07-15T03:34:03.254Z weekly 0.7 https://lifesciences.mofo.com/topics/fluoride-supplement-manufacturer-forced-to-address-misleading-labeling-allegations- 2022-07-06T00:09:27.125Z weekly 0.7 https://lifesciences.mofo.com/topics/traversing-higher-hurdles-for-functional-limitations-under-section-112 2022-07-06T00:09:22.772Z weekly 0.7